Because the p53 protein has a variety of important functions for the maintenance of cellular responses, disruption of the p53/ARF pathway has been reported in almost every type of cancer including hepatocellular carcinoma (HCC) [3]. Here, CDKN2A is linked to hepatocellular carcinoma.